Endogenous and exogenous glucocorticoids decrease plasma ghrelin in humans

Medical Department, University Hospital Innenstadt, Ziemssenstrasse 1, 80336 Munich, Germany. Baerbel.Otto@med.uni-muenchen.de

OBJECTIVE: The orexigenic and adipogenic peptide hormone ghrelin is predominantly produced and secreted by the stomach and seems to transduce changes in food intake to specific neuronal circuits in the brain. The activity of ghrelin also includes stimulatory effects on the corticotropic system. However, little is known about the influence of glucocorticoids on ghrelin levels. We therefore studied human plasma ghrelin levels in the presence and absence of elevated glucocorticoid levels of either endogenous or exogenous origin. METHODS: Plasma ghrelin levels were measured in five patients with chronic hypercortisolism (aged 29-58, median 46 years) due to Cushing's syndrome before and after successful surgery for the adenoma, and in eight healthy controls (aged 24-39, median 27.5 years) before and after 30 mg prednisolone (for 5 days) once a day in the morning (median body mass index (BMI) 22.7 kg/m(2)). Plasma ghrelin levels were measured with a commercially available radioimmunoassay. RESULTS: In patients with Cushing's syndrome, plasma ghrelin levels were low (median 363.2 pg/ml, range 161.9-525.7 pg/ml) and significantly increased by 26.6% (P=0.04) after successful surgery, while BMI decreased (median 26.2-24.0 kg/m(2), P=0.04). A strong negative correlation (r=-0.9, P=0.04) between changes in BMI and plasma ghrelin was observed. In healthy controls, plasma ghrelin levels (median 288.7 pg/ml, range 119.6-827.8 pg/ml) were significantly suppressed by 18.3% (P=0.04) after prednisolone treatment. CONCLUSIONS: We have shown for the first time that plasma ghrelin levels are decreased under endogenously or exogenously induced hypercortisolism, making ghrelin an unlikely candidate for causing the changes in energy balance or body composition characteristic of Cushing's disease. However, the reduced ghrelin secretion could reflect a compensation mechanism in reaction to the metabolic consequences of chronic hypercortisolism.

This article has been cited by other articles:

				R. Nass, L. S. Farhy, J. Liu, C. E. Prudom, M. L. Johnson, P. Veldhuis, S. S. Pezzoli, M. C. Oliveri, B. D. Gaylinn, H. M. Geysen, et al. Evidence for Acyl-Ghrelin Modulation of Growth Hormone Release in the Fed State J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1988 - 1994. [Abstract] [Full Text] [PDF]

				E. Lanyi, A. Varnagy, K. A Kovacs, T. Csermely, M. Szasz, and I. Szabo Ghrelin and acyl ghrelin in preterm infants and maternal blood: relationship with endocrine and anthropometric measures Eur. J. Endocrinol., January 1, 2008; 158(1): 27 - 33. [Abstract] [Full Text] [PDF]

				B. Beck and S. Richy Differential long-term dietary regulation of adipokines, ghrelin, or corticosterone: impact on adiposity J. Endocrinol., January 1, 2008; 196(1): 171 - 179. [Abstract] [Full Text] [PDF]

				M. D. DeBoer, X. X. Zhu, P. Levasseur, M. M. Meguid, S. Suzuki, A. Inui, J. E. Taylor, H. A. Halem, J. Z. Dong, R. Datta, et al. Ghrelin Treatment Causes Increased Food Intake and Retention of Lean Body Mass in a Rat Model of Cancer Cachexia Endocrinology, June 1, 2007; 148(6): 3004 - 3012. [Abstract] [Full Text] [PDF]

				L. Wang, N. R. Basa, A. Shaikh, A. Luckey, D. Heber, D. H. St-Pierre, and Y. Tache LPS inhibits fasted plasma ghrelin levels in rats: role of IL-1 and PGs and functional implications. Am J Physiol Gastrointest Liver Physiol, October 1, 2006; 291(4): G611 - G620. [Abstract] [Full Text] [PDF]

				A. J. Martinez-Fuentes, J. Moreno-Fernandez, R. Vazquez-Martinez, M. Duran-Prado, A. de la Riva, M. Tena-Sempere, C. Dieguez, L. Jimenez-Reina, S. M. Webb, A. Pumar, et al. Ghrelin Is Produced by and Directly Activates Corticotrope Cells from Adrenocorticotropin-Secreting Adenomas J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2225 - 2231. [Abstract] [Full Text] [PDF]

				T. Siahanidou, H. Mandyla, M. Vounatsou, D. Anagnostakis, I. Papassotiriou, and G. P. Chrousos Circulating Peptide YY Concentrations Are Higher in Preterm than Full-Term Infants and Correlate Negatively with Body Weight and Positively with Serum Ghrelin Concentrations Clin. Chem., November 1, 2005; 51(11): 2131 - 2137. [Abstract] [Full Text] [PDF]

				R. Giordano, A. Picu, U. Pagotto, R. De Iasio, L. Bonelli, F. Prodam, F. Broglio, L. Marafetti, R. Pasquali, M. Maccario, et al. The negative association between total ghrelin levels, body mass and insulin secretion is lost in hypercortisolemic patients with Cushing's disease Eur. J. Endocrinol., October 1, 2005; 153(4): 535 - 543. [Abstract] [Full Text] [PDF]

				E. D Bruder, L. Jacobson, and H. Raff Plasma leptin and ghrelin in the neonatal rat: interaction of dexamethasone and hypoxia J. Endocrinol., June 1, 2005; 185(3): 477 - 484. [Abstract] [Full Text] [PDF]

				U. Espelund, T. K. Hansen, K. Hojlund, H. Beck-Nielsen, J. T. Clausen, B. S. Hansen, H. Orskov, J. O. L. Jorgensen, and J. Frystyk Fasting Unmasks a Strong Inverse Association between Ghrelin and Cortisol in Serum: Studies in Obese and Normal-Weight Subjects J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 741 - 746. [Abstract] [Full Text] [PDF]